According to a new comprehensive report from The Insight Partners, the global ovarian cancer drugs market is observing ...

The most common signs and symptoms of ovarian cysts include: Pain, such as dull pelvic or abdominal pain, or sharp pain during activity; Bloating, or a feeling of fullness or heaviness in the abdomen; ...

A critical challenge arising during a surgical procedure for tumor removal is the determination of tumor margins. Gold nanorods (GNRs) conjugated to epidermal growth factor receptors (EGFR) (GNRs-EGFR ...

This study introduced a novel framework for quantifying cancer cell heterogeneity using single-cell RNA sequencing data. The framework comprised several scores aimed at uncovering the complexities of ...

Leydig cell tumors account for 0.1% of all ovarian tumors, and are a type of steroid cell tumor. The majority of the cases is diagnosed in the presence of a hyperandrogenic state with signs of ...

A new case report was published in Volume 12 of Oncoscience on May 22, 2025, titled "A rare case: Pure Sertoli cell tumor uncovered in atrophic ovary during postmenopausal vault prolapse evaluation." ...

Intra- and inter-tumoral heterogeneity are pervasive in cancer and manifest as a constellation of molecular alterations in tumor tissues. The late-stage clonal proliferation, partial selective sweeps, ...

The taxanes (paclitaxel and docetaxel) currently play an important role in the managment of cancers of the ovary, uterus and cervix. In each of these gynecologic malignancies, the drugs are ...

How a synthetic lipoprotein targets tumor metabolism to trigger cancer cell death. ... In the current study, investigators in the Thaxton laboratory ran a genetic screen on ovarian cancer cells.

Ernexa Therapeutics’ “Trojan Horse” stem cells can infiltrate ovarian tumors in mice, boosting T cell activity and leading to shrunken tumors and improved survival, the company announced in ...

SHANGHAI & CAMBRIDGE, Mass., June 02, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069) evaluating ...